Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

By B. Zethelius, L. Berglund, J. Sundström, E. Ingelsson, S. Basu, Anders Larsson, P. Venge, J. Árnlöv. New England Journal of Medicine, 2008

925 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5708071670c97267730b4957661ac3e6069adbad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. L. Chambless
2. Christie M. Ballantyne

In Immunology

1. Christie M. Ballantyne

Citations in the corpus

• Systems medicine: the future of medical genomics and healthcare (2009, background): “In a similar way, systems approaches are starting to have an impact on the study of immunological diseases [198], inflammation [199], infectious diseases such as tuberculosis [200], neurological diseases such as autism [201] and Alzheimer’s [202], respiratory diseases such as asthma [203], cardiovas”
• The IL-33/ST2 pathway: therapeutic target and novel biomarker (2008, methodology): “Recently, a study using data from the Uppsala Longitudinal Study of Adult Men (ULSAM) registry, evaluated a cohort of more than 1,000 Swedish men over a follow-up period of 10 year”
• Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the ARIC Study (2011, methodology): “study have been described previously.(7,8) Deaths were determined by review of hospital”